![Katherine Bowdish](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Katherine Bowdish
Directeur Général chez
PIC Therapeutics, Inc.
Profil
Katherine S.
Bowdish is the founder of Bird Rock Bio Sub, Inc. Currently, Dr. Bowdish is President, Chief Executive Officer & Director at PIC Therapeutics, Inc. since 2020.
Formerly, Dr. Bowdish was Independent Director at Adocia SA from 2021 to 2024.
Other former roles include Vice Chairman at Warp Drive Bio, Inc., Director at MyoKardia, Inc., Director at Portal Instruments, Inc., Director at Thermalin, Inc., President, Director & Chief Scientific Officer at Permeon Biologics, Inc., President at Alexion Pharmaceuticals, Inc. in 2009, Chief Executive & Scientific Officer at Prolifaron, Inc., President at Alexion Antibody Technologies, Vice President-Global Research & Development at Sanofi España SA, and Vice President Global R&D and Head of Sunrise at Sanofi-Sunrise from 2013 to 2019.
Education includes undergraduate studies at The College of William & Mary and a doctorate from Columbia University College of Physicians & Surgeons.
Postes actifs de Katherine Bowdish
| Sociétés | Poste | Début |
|---|---|---|
PIC Therapeutics, Inc.
 PIC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer therapeutics | Directeur Général | 12/08/2020 |
Anciens postes connus de Katherine Bowdish
| Sociétés | Poste | Fin |
|---|---|---|
| ADOCIA | Directeur/Membre du Conseil | 18/09/2024 |
Sanofi-Sunrise
 Sanofi-Sunrise Investment ManagersFinance Sanofi-sunrise focuses on early-stage investments in companies in biotech and digital health. It provides financing to early stage transactions. | Private Equity Investor | 28/02/2019 |
Bird Rock Bio Sub, Inc.
 Bird Rock Bio Sub, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Directeur Général | 20/06/2011 |
Thermalin, Inc.
 Thermalin, Inc. Pharmaceuticals: MajorHealth Technology Develops insulin treatments for patients with diabetes | Directeur/Membre du Conseil | - |
Portal Instruments, Inc.
 Portal Instruments, Inc. Medical SpecialtiesHealth Technology Operates as a medical device company that focuses on drug delivery systems | Directeur/Membre du Conseil | - |
Formation de Katherine Bowdish
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
3
Relations au 1er degré
15
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
MyoKardia, Inc.
 MyoKardia, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of cardiovascular diseases | Health Technology |
Portal Instruments, Inc.
Portal Instruments, Inc. Medical SpecialtiesHealth Technology Operates as a medical device company that focuses on drug delivery systems | Health Technology |
Prolifaron, Inc.
 Prolifaron, Inc. Medical SpecialtiesHealth Technology Develops antibodies addressing multiple disease areas | Health Technology |
The College of William & Mary
 The College of William & Mary Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bird Rock Bio Sub, Inc.
Bird Rock Bio Sub, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Adocia SA
 Adocia SA Pharmaceuticals: MajorHealth Technology Manufactures novel therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases | Health Technology |
Alexion Antibody Technologies
 Alexion Antibody Technologies Miscellaneous Commercial ServicesCommercial Services Develops therapeutic antibodies addressing multiple diseases | Commercial Services |
Sanofi España SA | |
Thermalin, Inc.
Thermalin, Inc. Pharmaceuticals: MajorHealth Technology Develops insulin treatments for patients with diabetes | Health Technology |
Permeon Biologics, Inc.
 Permeon Biologics, Inc. BiotechnologyHealth Technology Develops intracellular biotherapeutics platform to enhance drug delivery | Health Technology |
Warp Drive Bio, Inc.
 Warp Drive Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Focuses on proprietary genomic technology to discover drugs of natural origin | Commercial Services |
Columbia University College of Physicians & Surgeons
 Columbia University College of Physicians & Surgeons Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sanofi-Sunrise
Sanofi-Sunrise Investment ManagersFinance Sanofi-sunrise focuses on early-stage investments in companies in biotech and digital health. It provides financing to early stage transactions. | Finance |
PIC Therapeutics, Inc.
PIC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer therapeutics | Health Technology |
Choisissez Zonebourse 
